Latest IPO news

  • Kaboom! CR Pharma listing fetches $1.8bn

    China Resources Pharmaceutical Group priced its Hong Kong IPO near the middle of expectations on Friday morning, raising HK$14bn ($1.8bn) after investors stormed into the trade.

    • 21 Oct 2016
  • China’s GDS Holdings launches $270m US float

    Chinese data firm GDS Holdings has opened its potential $270.2m US IPO, which is expected to replicate the strong interest received by other recent listings in the country from Mainland names.

    • 20 Oct 2016
  • Asia trio reel in crowds with $1bn-plus IPOs

    China Resources Pharmaceutical Group, Samsung BioLogics and ZTO Express all have investors clamouring to join their IPOs, as they look to raise a combined $5.2bn.

    • 20 Oct 2016
  • CR Pharma narrows range on HK$15bn IPO

    China Resources Pharmaceutical Group has tightened the price range on its IPO, putting it on track to raise up to HK$14.8bn ($1.9bn), according to a banker on the deal.

    • 20 Oct 2016
  • Cofco Meat bags Brazilian cornerstone, JNBY opens IPO

    Brazil’s biggest producer of processed food BRF has signed up as a cornerstone investor on Cofco Meat Holdings’ HK$2.59bn ($333.9m) IPO, according to a statement from the São Paulo-based company.

    • 19 Oct 2016
  • ZTO, Samsung BioLogics draw crowds to IPOs

    ZTO Express and Samsung BioLogics are seeing bumper responses for their jumbo IPOs in the US and South Korea respectively, as bankers expect their bookbuilds to gain even more momentum.

    • 19 Oct 2016
  • Varun, PNB Housing eye $617m from IPOs

    PNB Housing Finance and Varun Beverages are launching their IPOs in India next week to raise a combined Rp41.1bn ($616.9m).

    • 19 Oct 2016
  • Doosan Bobcat IPO: look before you leap

    Doosan Bobcat and its IPO advisers were left red-faced after the company was forced to pull its W2.4tr ($2.2bn) float in South Korea last week. The deal is making a quick comeback and the leads have done what they can to turn the situation around. But the incident serves as an object lesson in how not to do an IPO.

    • 18 Oct 2016
  • Investors after strong dose of CR Pharma IPO

    China Resources Pharmaceutical Group is proving a hit with global investors, as its HK$15.7bn ($2.0bn) Hong Kong IPO is heavily oversubscribed, according to a banker at one of the leads.

    • 18 Oct 2016
  • Xin Point seeks nod for Hong Kong listing

    Chinese automotive component supplier Xin Point Holdings is looking to go public in Hong Kong, having filed for approval with the city's stock exchange.

    • 18 Oct 2016

IPO news archive

Panda Bonds Top Arrangers

Rank Arranger Total Volume Rmb (m) No. of Deals Share % by Volume
1 Bank of China (BOC) 7,500 5 22.26
2 Agricultural Bank of China (ABC) 4,000 2 11.87
2 Everbright Securities 4,000 1 11.87
4 Industrial and Commercial Bank of China (ICBC) 3,500 2 10.39
5 HSBC 3,000 2 8.90

Bookrunners of Asia-Pac (ex-Japan) ECM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 19 Oct 2016
1 CITIC Securities 14,399.87 54 6.41%
2 Morgan Stanley 11,680.45 48 5.20%
3 GF Securities Co Ltd 11,254.82 44 5.01%
4 Deutsche Bank 8,929.93 36 3.97%
5 China Securities Co Ltd 8,568.28 45 3.81%

Bookrunners of Asia Pacific (ex-Japan) G3 DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 11 Oct 2016
1 HSBC 24,211.67 144 4.82%
2 Citi 23,007.32 123 4.58%
3 Bank of America Merrill Lynch 20,229.47 98 4.03%
4 JPMorgan 18,255.12 103 3.63%
5 Goldman Sachs 11,241.68 45 2.24%